HealthyMe Rebrands as SanusEO as it Expands Chronic Disease Product Line
St. Louis, Missouri (PRWEB) July 20, 2015 -- HealthyMe Mobile Solutions, the industry innovator of health care focused Interactive Automated Text solutions, announces the rebranding of the company. The rebranding follows a period of expansion for the business which will now operate under the new name SanusEO (pronounced san-ús-ē-ō). With rebranding, the company introduces an expansion of chronic disease-focused products to their clients in the healthcare market. To support the expansion, SanusEO also plans to add employees to their sales and marketing team.
Commenting on the rebranding, Mary Louise Helbig, President and Chief Executive Officer, explains: “Rebranding of the company emphasizes our focus on both patients and care teams as we engage them in managing critical transition points for patients with chronic disease. We’re excited to rebrand the company because we believe the new name tells the more inclusive story.”
SanusEO, Latin for healthy advances, expresses the broad vision of the company which is to advance chronic disease patient health and wellbeing so that they can live longer and more productive lives while reducing healthcare costs. Chronic disease is life long and can be difficult to manage. SanusEO utilizes a combination of mobile texting programs for patients and web services to engage care team members when patients are most in need of help.
SanusEO introduces an expansion of chronic disease products which focus on chronic obstructive pulmonary disease (COPD) and joint replacements. The expansion of products adds to SanusEO’s current product line which provides mobile texting solutions for a variety of chronic diseases including diabetes and Congestive Heart Failure. The company’s clients include physician groups, hospitals, insurance companies, and more.
SanusEO continues to build on the organization’s proven results. In June, SSM DePaul Health Center and a research team from the Saint Louis University Center for Outcomes Research (SLUCOR) announced results of a pilot program showing a 57% decrease in 30-day readmissions for patients with diabetes who participated in SanusEO’s Transition Care Program.
For more information about SanusEO, please visit http://www.SanusEO.com
About SanusEO, LLC
SanusEO Inc. is a mHealth company offering mobile texting and web services to support population health management with a focus on improving both clinical and financial outcomes. SanusEO’s Patient Engagement Platform (PEP) provides care teams with daily alerts and access to real-time participant program data for both immediate and long-term intervention planning. SanusEO is an innovator of Interactive Automated Texting (IAT) solutions for healthcare patients, providers and insurers. SanusEO provides a simple to implement and use, cost-effective, mobile texting solution for a variety of chronic disease, including diabetes, Congestive Heart Failure (CHF), COPD, and joint replacements with multi-language capability. Please visit http://www.SanusEO.com for more information.
Connie Gallagher, SanusEO, http://www.sanuseo.com, +1 888-603-9062 Ext: 707, [email protected]
Share this article